Mice were injected intravenously with 110 mg/kg
alloxan (Sigma-Aldrich, St. Louis, MO, USA) in PBS (phosphate-buffered saline) at day 1. Mice with a blood glucose level greater than 500 mg/dl (
OneTouch Ultra Mini, Johnson & Johnson, Milpitas, CA, USA) were randomized into two groups. One group was injected with
caerulein (Sigma-Aldrich; six IP injections on days 1, 3 and 5). Lineage tracing studies were done with a
caerulein dose of 7 mg/kg and the time course study with C57BL/6 mice used a dose of 10 mg/kg in PBS. Mice (
alloxan alone and
alloxan plus
caerulein) were killed on days:
Day 13- Three C57BL/6
alloxan plus
caerulein mice, three C57BL/6
alloxan alone mice.
Day 20- Three lineage tracing
alloxan plus
caerulein mice, three lineage tracing
alloxan alone mice, seven C57BL/6
alloxan plus
caerulein mice, seven C57BL/6
alloxan alone mice. Of the seven C57BL/6
alloxan plus
caerulein mice and seven
alloxan alone mice, one group from each (
n=3) had
BrdU (1 mg/ml, Sigma-Aldrich) added to the drinking water, whereas the second (
n=4) had no
BrdU added.
Day 27- Three C57BL/6
alloxan plus
caerulein mice, three C57BL/6
alloxan alone mice.
Day 38- Three lineage tracing
alloxan plus
caerulein mice, three lineage tracing
alloxan alone mice, four C57BL/6
alloxan plus
caerulein and four C57BL/6
alloxan alone.
Piran R., Lee S.H., Li C.R., Charbono A., Bradley L.M, & Levine F. (2014). Pharmacological induction of pancreatic islet cell transdifferentiation: relevance to type I diabetes. Cell Death & Disease, 5(7), e1357-.